Mayo Clinic researchers will present over 30 studies at ASCO 2026, highlighting new advances in imaging AI, data science, and early cancer detection.
Key Details
- 1More than 30 Mayo Clinic studies will be featured at the 2026 ASCO Annual Meeting.
- 2Highlighted topics include precision oncology, early cancer detection, and AI-driven analysis.
- 3A deep learning approach will be presented to quantify tumor microenvironment features in colon cancer trials.
- 4Research includes multicancer early detection testing and biomarker-driven treatments for various cancers.
- 5Specific sessions will address AI-enabled analysis of postoperative ctDNA status and clinical outcomes.
Why It Matters
Presentations on AI-powered tissue analysis and early detection signal accelerating integration of imaging AI into oncology care. Such advances can inform best practices for radiologists and collaborative cancer care teams.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.